European Partnership Aims to Better Understand and Predict Immunotherapy Response – Immuno-Oncology News
Immuno-Oncology News |
European Partnership Aims to Better Understand and Predict Immunotherapy Response
Immuno-Oncology News Better predicting and monitoring immune-related adverse events in cancer patients being treated with immune checkpoint inhibitors is the goal of a partnership between Institut Gustave-Roussy, a leading cancer center based near Paris, and the German … |
